When bridal boutiques start asking customers to sign weight-loss waivers and bra companies redesign products for changing body elasticity, it's clear that GLP-1 medications have moved far beyond a healthcare story. As adoption of GLP-1 medications reaches 12% to 15% of the US population, per KFF survey data, retailers across every category are discovering that changing consumer behavior requires more than just smaller portion sizes.

"It's not really an appetite story or a customer segment that's just going to lose weight consistently," said our analyst Rajiv Leventhal on an episode of “Reimagining Retail.” "It's turned into a lifestyle and spending reallocation story."

The shift is forcing retailers to abandon old assumptions and rebuild strategies around a more complex reality: GLP-1 users aren't a static segment, but customers moving through different stages of a fluid journey.

The persistence problem retailers didn't see coming

Less than a third of GLP-1 patients remain on their medication regimen 13 months after starting, according to a November 2025 IQVIA analysis of GLP-1 prescription claims. This creates a revolving door of consumer needs that retailers must navigate.

"Everyone's at a different stage of their GLP-1 journey," Leventhal said. "Some may stop, they might regain weight and then come back on. While that's happening, others might start their first treatment journey."

Retailers can't design for a single GLP-1 customer profile. Instead, they need strategies that account for consumers experiencing side effects, losing weight rapidly, microdosing, maintaining weight loss, or cycling off the medication entirely. The customer who needs smaller portions today may need different products entirely in six months.

Why this isn't just about eating less

Early retail responses focused narrowly on reduced food consumption, but emerging data reveals a more nuanced spending pattern. GLP-1 users are actually trading up in certain categories while cutting back in others.

Fresh food and produce purchases are increasing among GLP-1 users, even as overall meal frequency decreases, per Leventhal.

"I'm eating one less meal a day, but I want the meals that I am eating to really matter and to really taste great," he said.

Similar patterns appear in dining, where GLP-1 users reduce casual restaurant visits but increase social dining occasions with friends or for work functions.

Positioning products as premium options for the meals that count can grow revenue from GLP-1 users instead of shrinking it.

The marketing trap to avoid

As GLP-1 adoption grows, some retailers are leaning heavily into "GLP-1-friendly" messaging and product labeling. But this approach risks alienating both GLP-1 users who don't want to be defined by their medication and the roughly 85% of US consumers not using these drugs, per the same KFF data.

"Not every GLP-1 user wants to be reminded that they're on GLP-1s," said our analyst Rachel Wolff. "There is still considerable hesitance among a lot of people to publicly proclaim that."

Some consumer-packaged goods (CPG) companies like Nestle have created dedicated GLP-1-friendly websites showcasing appropriate products without putting labels on every package. This allows users to self-select while maintaining privacy.

The most effective approach emphasizes product attributes that appeal to GLP-1 users without explicitly calling them out. This inclusive strategy serves multiple customer segments simultaneously.

Listen to the full episode

We prepared this article with the assistance of generative AI tools and stand behind its accuracy, quality, and originality.

This was originally featured in the Retail Daily newsletter. For more retail insights, statistics, and trends, subscribe here.